Breast Cancer Alliance (BCA) Celebrates 25 Years and Welcomes Three New Board Members

Breast Cancer Alliance (BCA) is excited to welcome three new dynamic board members, Amy Dates Carbone, Sandra Caruso and Stephanie Latham, to their Board of Directors as of April 1, 2021. “They bring years of experience, energy, and passion to our board,” said Yonni Wattenmaker, BCA’s Executive Director, ”helping to advance our mission and get closer to our ambitious goal of 100% breast cancer survival rate by 2030. We are celebrating the 25th anniversary of the founding of BCA and the future has never looked more promising”

The new BCA board members are:

Amy Dates Carbone: Amy spent nearly two decades as an executive in corporate communications on Wall Street and served as a spokesperson for Citibank. When she redirected her skill set to Greenwich philanthropy, she served on the boards of the United Way, Arch Street Teen Center, Project Blessing and the Junior League of Greenwich. Amy has volunteered at her children’s Greenwich schools and is thrilled that today her daughter is working in a research lab developing nanotechnology for breast cancer drug delivery. Amy is currently the Vice President of the Millbrook Owner’s Association and serves on the Case Western Reserve University Parent Leadership Council. Having watched both her mother and sister battle breast cancer successfully, Amy is fully committed to accelerating the work of Breast Cancer Alliance.

Sandra Caruso: Sandra has been a volunteer for BCA since 2016 when she walked the runway as a breast cancer survivor with the Models of Inspiration. She has served on the Research Grants Committee and the Education and Outreach Grants Committee since 2019. Sandra earned a B.A. from New York University and received her J.D. from New York Law School. She was an associate with several NYC law firms, focusing on medical and hospital practice litigation. In 2014, Sandra was diagnosed at age 44 with ER/PR-, Her2+ breast cancer, with no prior family history or risk factors. She was treated at Memorial Sloan-Kettering, where she underwent a double mastectomy, chemotherapy and a dual antibody blockade. She credits science, medical research, emerging new drugs and prayers for her current NED (no evidence of disease) status. Sandra is passionate about the BCA mission to support new and emerging scientists, scientific discovery and research, which are critical in advancing the discovery of better screening and new treatments for this disease. 

Stephanie Latham: Stephanie was born and raised in Wilton, CT and served on BCA’s Advisory Council last year. She received a B.A. from the University of Virginia and an MBA from New York University. Stephanie and her family lived in NYC and Greenwich before relocating to the San Francisco Bay area where she is an executive with Facebook, leading one of their largest Sales and Marketing Teams, partnering with technology companies on advertising strategies. Stephanie is a champion of women in the workplace, supporter of women entrepreneurs, small business owners and an advocate for more equitable parental leave policies. Stephanie was diagnosed with breast cancer when she was 31 and pregnant with her daughter Caroline. Shortly after she concluded her treatment plan, her mother was also diagnosed with Stage 2 breast cancer. Stephanie is thankful to report they are survivors and Caroline is a healthy five-year-old. Stephanie’s experience serves as a constant reminder of the work needed to be done to cure this disease and it inspires and energizes her to partner with BCA to ensure that all women get the screening they need and that the research to find a cure is well funded.

They will join BCA board members: Meg Russell, President, Michelle Abadir-Hallock, MD, Kim Augustine, Jill Coyle, Sue Delepine, Xandy Duffy, Donna Hagberg, MD, Mary K. Jeffery, Lois Kelly, Nina Lindia, Karen Lowney, Andrew Mitchell-Namdar, Justin Nelson, Courtney Olsen, Jordan Rhodes, Mary Jo Riddle, Barbara Rodkin, Nancy Rosen, Trish Shannon, Susan Weis, Jane Gershon Weitzman, Elisa Wilson, Diane Zarrilli, Molly Zola and Sharon Phillips, Trustee Emeritus.